-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
Neumora Therapeutics, Inc. quarterly/annual Depreciation, Depletion and Amortization history and growth rate from Q1 2023 to Q1 2024.
- Neumora Therapeutics, Inc. Depreciation, Depletion and Amortization for the quarter ending March 31, 2024 was $158K, unchanged year-over-year.
- Neumora Therapeutics, Inc. annual Depreciation, Depletion and Amortization for 2023 was $668K, a 12.5% increase from 2022.
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)